Akkermansia Muciniphila Supplementation Improves Metabolic Markers in Overweight Adults
Summary
A 16-week double-blind randomized controlled trial of 120 overweight adults demonstrated that daily supplementation with pasteurized Akkermansia muciniphila significantly improved insulin sensitivity, reduced waist circumference, and restored gut barrier integrity compared to a placebo. Additionally, the treatment group exhibited increased overall gut microbial diversity.
Why This Is Interesting
Akkermansia has been one of the most discussed 'next-generation probiotics' but human evidence was limited until now. This is the largest and longest human trial to date, confirming that the pasteurized form is both safe and effective. The gut barrier improvements are particularly noteworthy — intestinal permeability ('leaky gut') is increasingly linked to systemic inflammation, metabolic syndrome, and autoimmune conditions.
Published in Gut
"Akkermansia Muciniphila Supplementation Improves Metabolic Markers in Overweight Adults." Gut, 20 Mar. 2026, pubmed.ncbi.nlm.nih.gov/example9/.